Fogelholm M, Valve R, Kukkonen-Harjula K, Nenonen A, Hakkarainen V, Laakso M, Uusitupa M
The UKK Institute for Health Promotion and Research, Tampere, Finland.
J Clin Endocrinol Metab. 1998 Dec;83(12):4246-50. doi: 10.1210/jcem.83.12.5339.
This study examined whether the Trp64Arg mutation in the beta3-adrenergic receptor (beta3AR) and the A-->G mutation in the uncoupling protein-1 (UCP-1) genes have associations with weight loss and subsequent weight maintenance. Seventy-seven obese (body mass index range, 29-46 kg/m2), clinically healthy, premenopausal women were studied. A 12-wk weight reduction by very low calorie diet (VLCD) was followed by a 40-wk weight maintenance phase. The subjects were divided into four groups according to their beta3AR and UCP-1 genotype: no mutation (control; n=37), only Trp64Arg mutation in the beta3AR gene (n=12), only A-->G mutation in the UCP-1 gene (n=23), and both mutations (n=5). Subjects with both mutations had a lower weight reduction during VLCD than the controls [-10.5+/-0.6 (+/-SEM) vs. -14.0+/-0.5 kg; P=0.051, by ANOVA]. During the maintenance phase, weight in subjects with both mutations increased by 5.8+/-1.5 kg, but remained unchanged in the controls (-0.5+/-0.8 kg; P=0.041). The changes in weight in subjects with only one of the mutation were close to the results in the controls. Resting energy expenditure, adjusted for fat mass, fat-free mass, and maximal aerobic power, did not change differently between the groups throughout the study. The results suggest that a combination of the Trp64Arg mutation in the beta3AR and the A-->G mutation in the UCP-1 genes may be associated with faster weight gain after a VLCD.
本研究检测了β3-肾上腺素能受体(β3AR)中的色氨酸64精氨酸(Trp64Arg)突变以及解偶联蛋白-1(UCP-1)基因中的A→G突变是否与体重减轻及随后的体重维持有关。对77名肥胖(体重指数范围为29 - 46 kg/m²)、临床健康的绝经前女性进行了研究。先通过极低热量饮食(VLCD)进行12周的体重减轻,随后是40周的体重维持阶段。根据受试者的β3AR和UCP-1基因型将其分为四组:无突变(对照组;n = 37)、仅β3AR基因中的Trp64Arg突变(n = 12)、仅UCP-1基因中的A→G突变(n = 23)以及两种突变均有(n = 5)。两种突变均有的受试者在VLCD期间体重减轻幅度低于对照组[-10.5±0.6(±SEM)对-14.0±0.5 kg;方差分析,P = 0.051]。在维持阶段,两种突变均有的受试者体重增加了5.8±1.5 kg,而对照组体重无变化(-0.5±0.8 kg;P = 0.041)。仅有一种突变的受试者体重变化与对照组结果接近。在整个研究过程中,经脂肪量、去脂体重和最大有氧能力校正后的静息能量消耗在各组之间的变化无差异。结果表明,β3AR中的Trp64Arg突变与UCP-1基因中的A→G突变共同作用可能与VLCD后体重更快增加有关。